title: Group B meningococcal vaccine: recommendations for UK use.
authors.affiliation: Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Pollard
authors.affiliation: Alder Hey Children's NHS Foundation, Liverpool, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Riordan
authors.affiliation: Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, UK.
authors.forename: Mary
authors.initials: M
authors.lastname: Ramsay
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D017589:Immunization Programs / Q000191:economics; D007223:Infant; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D038541:Neisseria meningitidis, Serogroup B; D006113:United Kingdom
chemical_list: C570015:4CMenB vaccine; D022401:Meningococcal Vaccines